Cell line · CVCL_9773
Papers127
22 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 127
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Genetic dissection of cell type-specific congenital heart disease variants reveals ETS1 control of vascular smooth muscle cell fate. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| HOPX regulates the development and lineage progression of human stem cell-derived outer radial glia-like cells. | Stem Cell Reports | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Brain assembloids reveal efficacy and off target effects in high grade glioma brain cancer. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Combining in vitro and in silico approaches to model neural tube patterning and isthmic organizer formation. | NPJ Syst Biol Appl | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Label-free biochemical imaging and time point analysis of neural organoids via deep learning-enhanced Raman microspectroscopy. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| NeuroSuite for Long-Term Functional and Structural Studies of Air-Liquid Interface Cerebral Organoids. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Ligand-independent EPHA2 signaling sustains neural progenitors via ECSIT and NAD. | EMBO Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Scalable hypothalamic neuron differentiation from human pluripotent stem cells suitable for modeling metabolic disorders. | Stem Cell Reports | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A human corticospinal organoid-slice connectoid model informs enhancer strategies for post-injury axon regrowth. | Cell Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids. | J Neurochem | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Actomyosin contractility is a potent suppressor of mesoderm induction by human pluripotent stem cells. | J Cell Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mitochondrial Fission Regulator 1-Like Protein Protects the Heart from Ischemia/Reperfusion Injury via Dual Mitochondrial Mechanisms. | Research (Wash D C) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Engineering scalable vascularized kidney organoids for in vivo glomerular filtration with human endothelial integration. | NPJ Biomed Innov | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Human Myelin Spheres for in Vitro Oligodendrocyte Maturation, Myelination and Neurological Disease Modeling. | Stem Cell Rev Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline glioma. | Cancer Cell | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Comprehensive Profiling of N6-methyladnosine (m6A) Readouts Reveals Novel m6A Readers That Regulate Human Embryonic Stem Cell Differentiation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Multimodal electroconductive PLGA-based scaffold orchestrates neuroprotection and regeneration following severe spinal cord injury. | J Nanobiotechnology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| The Alzheimer's therapeutic Lecanemab attenuates Aβ pathology by inducing an amyloid-clearing program in microglia. | Nat Neurosci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Hedgehog signaling activation rescues hypoxia-induced ferroptosis in human brain organoids. | Neural Regen Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_9773/papers